EA202192291A1 - Композиция, содержащая стабильную в течение длительного времени живую фекальную микробиоту - Google Patents
Композиция, содержащая стабильную в течение длительного времени живую фекальную микробиотуInfo
- Publication number
- EA202192291A1 EA202192291A1 EA202192291A EA202192291A EA202192291A1 EA 202192291 A1 EA202192291 A1 EA 202192291A1 EA 202192291 A EA202192291 A EA 202192291A EA 202192291 A EA202192291 A EA 202192291A EA 202192291 A1 EA202192291 A1 EA 202192291A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- composition
- composition containing
- term stable
- containing long
- fecal microbiota
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 241000736262 Microbiota Species 0.000 title 1
- 230000002550 fecal effect Effects 0.000 title 1
- 230000007774 longterm Effects 0.000 title 1
- 244000005700 microbiome Species 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Botany (AREA)
- Zoology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19382287 | 2019-04-15 | ||
| PCT/EP2020/060370 WO2020212297A1 (en) | 2019-04-15 | 2020-04-14 | Long-term stable live fecal microbiota composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA202192291A1 true EA202192291A1 (ru) | 2022-02-11 |
Family
ID=66349477
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA202192291A EA202192291A1 (ru) | 2019-04-15 | 2020-04-14 | Композиция, содержащая стабильную в течение длительного времени живую фекальную микробиоту |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US20220143107A1 (https=) |
| EP (2) | EP3955899B1 (https=) |
| JP (1) | JP2022529008A (https=) |
| KR (1) | KR20210152505A (https=) |
| CN (1) | CN113710237B (https=) |
| AU (1) | AU2020259740B2 (https=) |
| BR (1) | BR112021020606A2 (https=) |
| CA (1) | CA3130816A1 (https=) |
| DK (1) | DK3955899T3 (https=) |
| EA (1) | EA202192291A1 (https=) |
| ES (1) | ES3035981T3 (https=) |
| FI (1) | FI3955899T3 (https=) |
| IL (1) | IL287238A (https=) |
| MX (1) | MX2021011246A (https=) |
| PH (1) | PH12021552573A1 (https=) |
| PL (1) | PL3955899T3 (https=) |
| PT (1) | PT3955899T (https=) |
| SG (1) | SG11202110641XA (https=) |
| WO (1) | WO2020212297A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112017024265B1 (pt) | 2015-05-11 | 2022-08-09 | Mybiotics Pharma Ltd | Métodos para crescimento de um biofilme de bactérias probióticas em partículas sólidas |
| IL294171A (en) | 2016-05-25 | 2022-08-01 | Mybiotics Pharma Ltd | Composition and methods for microbiota therapy |
| EP3955899B1 (en) | 2019-04-15 | 2025-05-07 | Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS) | Long-term stable live microbiota composition |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1190386A (en) * | 1966-06-28 | 1970-05-06 | Green Cross Corp | Process for producing the Lactic Acid Bacteria Drugs |
| FR2708621B1 (fr) * | 1993-07-29 | 1995-10-20 | Lesaffre & Cie | Biomasse stable à base de cellules de levure et de bactéries lactiques et procédé de préparation. |
| ITMI20011632A1 (it) | 2001-07-27 | 2003-01-27 | Sanofi Synthelabo | Composizione solida contenente spore di batteri non patogeni del genere bacillus |
| US20050266069A1 (en) | 2002-09-06 | 2005-12-01 | Simmons Donald L | Stable probiotic microsphere compositions and their methods of preparation |
| US20050100559A1 (en) * | 2003-11-07 | 2005-05-12 | The Procter & Gamble Company | Stabilized compositions comprising a probiotic |
| GB0330009D0 (en) * | 2003-12-24 | 2004-01-28 | Ferrosan As | Probiotic tablet formulations |
| CA2623968C (en) | 2005-09-29 | 2014-12-09 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | Method for stabilising pharmaceutical administration forms comprising microorganisms |
| DE102005062731A1 (de) * | 2005-12-22 | 2007-06-28 | Organobalance Gmbh | Neue Lactobacillus Stämme und deren Verwendung |
| TR200800634A2 (tr) * | 2008-01-30 | 2009-02-23 | Takka Sevgi̇ | Uzatılmış salım sağlayan fluvastatin tablet. |
| CA2808610C (en) * | 2010-08-10 | 2018-09-25 | R.P. Scherer Technologies, Llc | Process of manufacturing a stable softgel capsule containing microencapsulated probiotic bacteria |
| CN104095180A (zh) * | 2013-04-12 | 2014-10-15 | 中国科学院烟台海岸带研究所 | 一种益生菌菊粉片及其制备方法 |
| US10583420B2 (en) * | 2014-10-01 | 2020-03-10 | 7905122 Canada Inc. | Process and apparatus for manufacturing water-absorbing material and use in cat litter |
| WO2016178775A1 (en) * | 2015-05-01 | 2016-11-10 | Microbiome Health Research Institute Inc. | Compositions and methods for therapeutic delivery of microbial communities |
| CN104922158B (zh) * | 2015-06-05 | 2018-11-02 | 中国人民解放军第三军医大学第三附属医院 | 粪菌胶囊及其制备与应用 |
| US10905726B2 (en) | 2015-06-09 | 2021-02-02 | Rebiotix, Inc. | Microbiota restoration therapy (MRT) compositions and methods of manufacture |
| CN109414048B (zh) * | 2016-06-30 | 2023-09-01 | 弗门尼舍有限公司 | 包衣酵母配方 |
| US20200147151A1 (en) * | 2017-01-30 | 2020-05-14 | The Board Of Regents Of The University Of Texas System | Compositions and methods for fecal microbiota transplantation |
| US20200188310A1 (en) | 2017-08-29 | 2020-06-18 | Chr. Hansen A/S | Stable capsules with fecal microbiota or a culture of microorganisms |
| CN108567799A (zh) * | 2018-08-01 | 2018-09-25 | 中国人民解放军总医院 | 一种全粪菌复合胶囊及其制备方法和应用 |
| EP3955899B1 (en) | 2019-04-15 | 2025-05-07 | Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS) | Long-term stable live microbiota composition |
-
2020
- 2020-04-14 EP EP20716843.6A patent/EP3955899B1/en active Active
- 2020-04-14 WO PCT/EP2020/060370 patent/WO2020212297A1/en not_active Ceased
- 2020-04-14 DK DK20716843.6T patent/DK3955899T3/da active
- 2020-04-14 MX MX2021011246A patent/MX2021011246A/es unknown
- 2020-04-14 FI FIEP20716843.6T patent/FI3955899T3/fi active
- 2020-04-14 BR BR112021020606A patent/BR112021020606A2/pt unknown
- 2020-04-14 PH PH1/2021/552573A patent/PH12021552573A1/en unknown
- 2020-04-14 SG SG11202110641XA patent/SG11202110641XA/en unknown
- 2020-04-14 PT PT207168436T patent/PT3955899T/pt unknown
- 2020-04-14 KR KR1020217036103A patent/KR20210152505A/ko active Pending
- 2020-04-14 CN CN202080029290.6A patent/CN113710237B/zh active Active
- 2020-04-14 ES ES20716843T patent/ES3035981T3/es active Active
- 2020-04-14 AU AU2020259740A patent/AU2020259740B2/en active Active
- 2020-04-14 EA EA202192291A patent/EA202192291A1/ru unknown
- 2020-04-14 EP EP25174121.1A patent/EP4609873A3/en active Pending
- 2020-04-14 US US17/602,134 patent/US20220143107A1/en active Pending
- 2020-04-14 PL PL20716843.6T patent/PL3955899T3/pl unknown
- 2020-04-14 CA CA3130816A patent/CA3130816A1/en active Pending
- 2020-04-14 JP JP2021561644A patent/JP2022529008A/ja active Pending
-
2021
- 2021-10-13 IL IL287238A patent/IL287238A/en unknown
-
2023
- 2023-12-15 US US18/541,995 patent/US12521422B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR20210152505A (ko) | 2021-12-15 |
| EP4609873A2 (en) | 2025-09-03 |
| EP3955899B1 (en) | 2025-05-07 |
| PT3955899T (pt) | 2025-07-18 |
| DK3955899T3 (da) | 2025-08-04 |
| BR112021020606A2 (pt) | 2021-12-07 |
| AU2020259740B2 (en) | 2025-12-18 |
| AU2020259740A1 (en) | 2021-10-28 |
| MX2021011246A (es) | 2022-01-18 |
| IL287238A (en) | 2021-12-01 |
| SG11202110641XA (en) | 2021-10-28 |
| JP2022529008A (ja) | 2022-06-16 |
| EP4609873A3 (en) | 2025-11-12 |
| CN113710237A (zh) | 2021-11-26 |
| CN113710237B (zh) | 2026-04-03 |
| WO2020212297A1 (en) | 2020-10-22 |
| EP3955899A1 (en) | 2022-02-23 |
| PH12021552573A1 (en) | 2022-07-04 |
| US20240131085A1 (en) | 2024-04-25 |
| FI3955899T3 (fi) | 2025-07-28 |
| US12521422B2 (en) | 2026-01-13 |
| PL3955899T3 (pl) | 2025-09-22 |
| CA3130816A1 (en) | 2020-10-22 |
| ES3035981T3 (en) | 2025-09-11 |
| US20220143107A1 (en) | 2022-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA202192291A1 (ru) | Композиция, содержащая стабильную в течение длительного времени живую фекальную микробиоту | |
| EA200601799A1 (ru) | Гидразидсодержащие соединения - ингибиторы cftr и их применение | |
| CY1116874T1 (el) | Δοσολογικο σχημα για τη χορηγηση ενος cd19xcd3 αμφιειδικου αντισωματος | |
| EA200800161A1 (ru) | Новые фармацевтические композиции с модифицированным высвобождением и способ получения таких композиций | |
| EA200701519A1 (ru) | Живая аттенуированная ротавирусная вакцина для перорального введения | |
| CY1105202T1 (el) | Διασπειρομενες φαρμακευτικες συνθεσεις | |
| AR026916A1 (es) | Combinaciones farmaceuticas y su uso en el tratamiento de desordenes gastrointestinales | |
| ITBO20110012A1 (it) | Composizioni farmaceutiche comprendenti rifaximina e loro uso. | |
| EA200870469A1 (ru) | Новые, содержащие нимесулид, фармацевтические композиции с низкой дозой, их получение и применение | |
| RU2012100709A (ru) | Новые фармацевтические композиции, содержащие прегабалин | |
| MX2021014774A (es) | Formulaciones de liberacion modificada y usos de las mismas. | |
| EA202190544A1 (ru) | Применение распадающихся в полости рта таблеток рилузола для лечения заболеваний | |
| EA201070315A1 (ru) | Жидкая лекарственная форма конъюгата | |
| ES2635353T3 (es) | Formas de dosificación y usos terapéuticos de la L-4-cloroquinurenina | |
| RU2014126879A (ru) | Композиции акампросата, способы их применения и содержащие их комбинации | |
| RU2013157834A (ru) | Композиции для подкожного введения физиологически активных средств | |
| RU2016137926A (ru) | Композиции грапипранта и способы их применения | |
| MY193963A (en) | Composition for treating joint diseases and kit containing same | |
| RU2010146309A (ru) | Фармацевтическая композиция для лечения фибромиалгии | |
| RU2018125252A (ru) | Синергическая комбинация пирролидонкарбоновой кислоты и/или ее солей и гиалуроновой кислоты и/или ее солей для применения в лечении и/или профилактике сухости и раздражения слизистых оболочек, и связанные фармацевтические композиции | |
| EA202290122A1 (ru) | Фармацевтические композиции в форме геля, содержащие ксилоглюкан и спирты, для регулируемого высвобождения активных ингредиентов | |
| GEAP202516774A (en) | Compactable oral formulations of ibutamoren | |
| JP2013126971A (ja) | 抗感冒剤 | |
| EA200500957A1 (ru) | Применение l-допа, его производных и лекарственных средств, содержащих эти соединения, для профилактики психотических заболеваний | |
| FR3072567A1 (fr) | Composition pharmaceutique ou dietetique contenant de l’extrait d’origanum majorana et utilisable pour reguler le cycle enterosystemique intestinal de l’eau. |